- Supply chain disruptions (not explicitly stated, but implied by the focus on supply chain management)
- Ensuring compliance with social and environmental standards across a diverse supply chain.
CHEPLAPHARM SE
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, CHEPLAPHARM SE disclosed greenhouse gas emissions of 130.9 tCO2e (Scope 1) + 16 tCO2e (Scope 2). By scope: Scope 1: 130.9 tCO2e/year; Scope 2: 16 tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
130.9 tCO2e (Scope 1) + 16 tCO2e (Scope 2)
2023
Renewable Energy
100% (electricity at German sites)
of total energy
Water Usage
1.9K m3/year
2023
Waste
76.2 tons/year
2023
Energy Use
1.1K MWh/year
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 130.9 tCO2e/year |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 16 tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 130.9 tCO2e (Scope 1) + 16 tCO2e (Scope 2) |
| 2022 | 267 tCO2 (Scope 2) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Switched entire electricity consumption at German sites to renewable energy sources, leading to a 92% reduction in Scope 2 emissions.
- New Greifswald office building meets EG40EE energy standard and covers >55% of its energy needs with environmental heat and self-generated electricity.
🎯 Climate & Sustainability Targets
🔜 Short-term
- Update 2022 materiality analysis according to new legal requirements (CSRD).
📅 Medium-term
- Prepare for EU Taxonomy and CSRD requirements (by 2025).
🌱 ESG Focus Areas
PatientsAttractive EmployerProduct Quality and SafetySocial and Ecological Supply Chain